HAVN Life Sciences's total assets for Q3 2023 were C$1.38M, a decrease of -14.52% from the previous quarter. DE:5NP0 total liabilities were C$540.44K for the fiscal quarter, a -19.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
